J&J's Talcum Trial Losses Create Litigation Powder Keg

By Brandon Lowrey (May 4, 2016, 6:03 PM EDT) -- Johnson & Johnson suffered serious defeats totaling $127 million in the first two trials in St. Louis over the alleged link between its talcum baby powder and ovarian cancer, and while J&J is appealing both verdicts, it still faces thousands of similar suits from consumers emboldened by headline-grabbing awards.

The corporation has said it will appeal both verdicts — Monday's $55 million award and a $72 million award from February. Two more trials are slated for September in New Jersey and St. Louis and as of a month ago, upward of 1,200 similar lawsuits had been filed.

While the pair of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!